Evommune (EVMN) EBIT (2024 - 2026)
Evommune (EVMN) posted quarterly EBIT of -$24.0 million for Q1 2026, down 59.35% year-over-year from -$58.9 million in Q1 2025, and up 19.39% quarter-over-quarter from -$29.7 million in Q4 2025.
Evommune (EVMN) EBIT (2024 - 2026) Analysis & Trends
Evommune (EVMN) has reported EBIT for 3 consecutive years, with -$24.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT fell 59.35% year-over-year to -$24.0 million; the TTM figure through Mar 2026 stood at -$82.0 million (changed N/A YoY), while the FY2025 annual figure was -$81.1 million, down 15.79% from the prior year.
- EBIT grew to -$24.0 million in Q1 2026 per EVMN's latest filing, from -$29.7 million in the prior quarter.
- Across five years, EBIT topped out at -$13.3 million in Q3 2025 and bottomed at -$29.7 million in Q4 2025.
- Historically, EBIT has averaged -$20.0 million across 3 years, with a median of -$19.0 million in 2024.
- Annual changes were most pronounced in 2025 — EBIT climbed 19.31% — and 2026, when it plunged 59.35%.
- Evommune's EBIT stood at -$21.5 million in 2024, then plunged by 38.51% to -$29.7 million in 2025, then advanced by 19.39% to -$24.0 million in 2026.
- Business Quant data shows EVMN's EBIT at -$24.0 million in Q1 2026, -$29.7 million in Q4 2025, and -$13.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Evommune | 531.53 Mn | 330.73 Mn | - | -34.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.90 Mn |
| Mar 31, 2026 | -23.95 Mn |
| Dec 31, 2025 | -29.72 Mn |
| Sep 30, 2025 | -13.33 Mn |
| Mar 31, 2025 | -15.03 Mn |
| Dec 31, 2024 | -21.45 Mn |
| Sep 30, 2024 | -16.52 Mn |